Explore Citius Pharmaceuticals' Q4 2024 financial report highlighting significant losses, R&D investments, and a cautious hold recommendation for investors navigating a complex market.
Explore Citius Pharmaceuticals, Inc.'s 8-K report from February 14, 2025. Key insights include stock details, company info, and significant SEC disclosures essential for investors.
Explore Citius Pharmaceuticals' 8-K filing detailing major events as of January 7, 2025. Learn about their securities, financial snapshot, and corporate details.
Explore Citius Pharmaceuticals, Inc.'s latest 8-K filing from January 7, 2025, detailing significant corporate events and financial insights. Stay informed with CTXR stock updates.
Explore Citius Pharmaceuticals, Inc. (CTXR) Q4 2024 financial report highlighting liquidity issues, R&D investments, and a stock recommendation to hold amid challenging market conditions.
Explore Citius Pharmaceuticals, Inc.'s latest Form 8-K filing dated December 27, 2024. Key insights on stock metrics and financial data included.
Explore Citius Pharmaceuticals' 8-K filing from December 18, 2024, detailing significant corporate changes and financial metrics. Stay informed on CTXR's latest developments.